Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Betting On Alere Inc (ALR)

Page 1 of 2

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many resources and use tools that are not always available for the general crowd. This doesn’t mean that they don’t have occasional colossal losses; they do (like Ackman’s recent Valeant losses). However, it is still a good idea to keep an eye on hedge fund activity. With this in mind, as the current round of 13F filings has just ended, let’s examine the smart money sentiment towards Alere Inc (NYSE:ALR).

Alere Inc (NYSE:ALR) was in 39 hedge funds’ portfolios at the end of September. ALR investors should pay attention to an increase in support from the world’s most elite money managers lately. There were 36 hedge funds in our database with ALR positions at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Arista Networks Inc (NYSE:ANET), Columbia Sportswear Company (NASDAQ:COLM), and Diamondback Energy Inc (NASDAQ:FANG) to gather more data points.

Follow Alere Inc. (NYSE:ALR)
Trade (NYSE:ALR) Now!

In the eyes of most shareholders, hedge funds are assumed to be unimportant, old investment tools of years past. While there are greater than an 8000 funds in operation at the moment, Our experts hone in on the bigwigs of this group, about 700 funds. These hedge fund managers manage bulk of the smart money’s total asset base, and by shadowing their top stock picks, Insider Monkey has formulated numerous investment strategies that have historically outrun the broader indices. Insider Monkey’s small-cap hedge fund strategy surpassed the S&P 500 index by 12 percentage points a year for a decade in their back tests.

Now, let’s take a peek at the latest action surrounding Alere Inc (NYSE:ALR).

What does the smart money think about Alere Inc (NYSE:ALR)?

At Q3’s end, a total of 39 of the hedge funds tracked by Insider Monkey were long this stock, a change of 8% from the previous quarter. With the smart money’s positions undergoing their usual ebb and flow, there exists an “upper tier” of notable hedge fund managers who were boosting their holdings significantly (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Scopia Capital, managed by Matt Sirovich and Jeremy Mindich, holds the biggest position in Alere Inc (NYSE:ALR). Scopia Capital has a $234.1 million position in the stock, comprising 5% of its 13F portfolio. The second largest stake is held by Iridian Asset Management, managed by David Cohen and Harold Levy, which holds a $214.8 million position; 1.8% of its 13F portfolio is allocated to the stock. Remaining members of the smart money that are bullish contain Doug Silverman and Alexander Klabin’s Senator Investment Group, William B. Gray’s Orbis Investment Management and Clifford Fox’s Columbus Circle Investors.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!